Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
05/04/2011 | CN101142180B Pyrrolidine derivatives as histamine h3 receptor antagonists |
05/03/2011 | US7935833 Compound containing carboxylate ester and N2S2 ligand bi-functional groups and manufacturing method thereof |
05/03/2011 | US7935832 Pyrrole and isoindole carboxamide derivatives as P2X7 modulators |
05/03/2011 | CA2438480C Glucocorticoid receptor modulators |
04/28/2011 | WO2011050030A1 Alpha adrenergic receptor modulators |
04/28/2011 | US20110098468 Nk1 antagonists |
04/28/2011 | US20110098336 Pyrrolidin-2-one derivatives as androgen receptor modulator |
04/28/2011 | US20110098334 Novel crystalline form of calcium zofenopril |
04/28/2011 | US20110098319 Fatty acid derivatives for oral administration endowed with high palatability |
04/28/2011 | US20110098309 Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds |
04/28/2011 | US20110098302 Cyclic diaryl ether compounds as antagonists of prostaglandin d2 receptors |
04/28/2011 | US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands |
04/28/2011 | US20110098281 Benzenesulfonyl Compounds and the Use Thereof |
04/28/2011 | US20110098276 Oxycarbamoyl compounds and the use thereof |
04/28/2011 | US20110098221 INHIBITORS OF Akt ACTIVITY |
04/28/2011 | US20110097735 Fluorescent pyrene compounds |
04/28/2011 | CA2779298A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
04/28/2011 | CA2778423A1 Alpha adrenergic receptor modulators |
04/27/2011 | EP2313412A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof |
04/27/2011 | EP2313371A1 Process for preparing a 3-pyrrole substituted 2-indolinone malate salt |
04/27/2011 | EP2313370A1 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
04/27/2011 | CN102036956A Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain |
04/27/2011 | CN102036955A Hydroxamate-based inhibitors of deacetylases b |
04/27/2011 | CN102036953A Arylsulfonamide-based matrix metalloprotease inhibitors |
04/27/2011 | CN102036936A Novel [F-18]-labelled l-glutamic acid and l-glutamine derivatives (II), use thereof and method for their production |
04/27/2011 | CN102030783A One-dimensional micron or submicron material of metal organic platinum (II) coordination compounds and preparation method and application |
04/27/2011 | CN102030700A Benzamide carboxylic acid compound as well as manufacturing method and medicinal application thereof |
04/27/2011 | CN102030695A Method for preparing bactericide N-(2,4,6-trichlorophenyl) maleimide |
04/27/2011 | CN102030653A Polymerizable compound |
04/27/2011 | CN102029156A Process for preparing of [gamma]-butyrolactone and n-methyl pyrrolidone from 1,4-butanediol |
04/27/2011 | CN101157650B Method for preparation of indole-1-methyl formate and its derivatives |
04/26/2011 | US7932403 Process for preparing pyrrole derivatives and intermediates |
04/26/2011 | US7932388 Intermediates of active esters for peptide synthesis, labeling, analysis; purity |
04/26/2011 | US7932381 Process for producing carbapenem derivative and intermediate crystal therefor |
04/26/2011 | US7932285 Compounds from Antrodia camphorata |
04/26/2011 | US7932277 Peptide inhibitors of hepatitis C virus replication |
04/26/2011 | CA2546970C Imidazole derivatives, processes for preparing them and their uses |
04/26/2011 | CA2446778C Process for preparing polyisocyanates |
04/26/2011 | CA2400871C Novel malconic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
04/26/2011 | CA2345103C (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
04/26/2011 | CA2322194C Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes |
04/21/2011 | WO2011047192A2 Protected amine labels and use in detecting analytes |
04/21/2011 | WO2011047190A1 Gamma amino acid building blocks |
04/21/2011 | WO2011046954A1 Hematopoietic growth factor mimetic small molecule compounds and their uses |
04/21/2011 | WO2011046597A2 Biomarkers for the detection of breast cancer |
04/21/2011 | WO2011046007A1 Process for preparation of diethylenetriaminepentaacetic acid derivatives, and diethylenetriaminepentaacetic acid derivatives |
04/21/2011 | WO2011045259A1 Aminopropenoates as fungicides |
04/21/2011 | WO2011045257A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
04/21/2011 | US20110092683 Phosphonium salts derivatives and uses thereof |
04/21/2011 | US20110092559 Pyrrole and pyrazole daao inhibitors |
04/21/2011 | US20110092557 Neuraminidase Inhibitors And Compositions And Methods Related Thereto |
04/21/2011 | US20110092368 2,4,6-Phenyl-substituted cyclic ketoenols |
04/21/2011 | CA2774512A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
04/21/2011 | CA2774250A1 C-linked hydroxamic acid derivatives useful as antibacterial agents |
04/20/2011 | EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
04/20/2011 | EP2311804A2 Method for preparing n-substituted maleimides |
04/20/2011 | EP2311803A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
04/20/2011 | EP2311802A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
04/20/2011 | EP2311451A1 Amino-methyl substituted tetracycline compounds |
04/20/2011 | EP2310362A1 Formation of 18f and 19f fluoroarenes bearing reactive functionalities |
04/20/2011 | EP2310361A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues |
04/20/2011 | EP2310360A1 Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives |
04/20/2011 | EP1889834B1 Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same |
04/20/2011 | EP1720872B1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors |
04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
04/20/2011 | CN1910147B Malononitrile compound and use thereof |
04/20/2011 | CN1902194B Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methyl)-pyrrol-1-yl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
04/20/2011 | CN102026970A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
04/20/2011 | CN102026969A Novel N-(2-amino-phenyl)-acrylamides |
04/20/2011 | CN102026961A Amide compound |
04/20/2011 | CN102023483A Photoresist composition |
04/20/2011 | CN101602703B Pyrrole group-containing compound and preparation method and application thereof |
04/20/2011 | CN101462996B Preparation of 4-cyclohexyl proline derivative |
04/20/2011 | CN101094860B Metal complex compound and organic electroluminescent element using the same |
04/19/2011 | US7928228 Triazolone derivatives |
04/19/2011 | US7928037 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
04/19/2011 | CA2498851C Heterocyclocarboxamide derivatives |
04/16/2011 | CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
04/14/2011 | WO2011044229A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
04/14/2011 | WO2011044225A1 Modulators of g protein-coupled receptor 88 |
04/14/2011 | WO2011044073A1 Pyrrolidine gpr40 modulators |
04/14/2011 | WO2011044057A1 Sulfonamido pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof |
04/14/2011 | WO2011043480A1 Homocysteine synthase inhibitor |
04/14/2011 | WO2011042765A1 Inorganic salt complexes of vildagliptin |
04/14/2011 | WO2011042654A1 P-glycoprotein-specific non-competitive peptide and peptidomimetic modulators |
04/14/2011 | WO2011042477A1 Substituted pyrroles and imidazoles as estrogen receptor ligands |
04/14/2011 | WO2011042473A2 Novel estrogen receptor ligands |
04/14/2011 | US20110086879 Carboxamide compounds and their use as calpain inhibitors |
04/14/2011 | US20110086854 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
04/14/2011 | US20110086822 Substituted Tetracycline Compounds |
04/14/2011 | US20110086409 Surfactant-Based Monolithic Columns, Methods for Making the Same, and Method for Using the Same |
04/14/2011 | US20110086369 Fluorescent compounds for the diagnosis of infections, production method, and applications thereof |
04/14/2011 | CA2777041A1 Pyrrolidine gpr40 modulators |
04/14/2011 | CA2776260A1 P-glycoprotein-specific non-competitive peptide and peptidomimetic modulators |
04/14/2011 | CA2776005A1 Inorganic salt complexes of vildagliptin |
04/13/2011 | EP2308838A1 Nitrogen-containing aromatic heterocyclyl compound |
04/13/2011 | EP2308812A2 N-acylsulfonamide apoptosis promoters |
04/13/2011 | EP2307017A1 Compounds which can be used for the treatment of cancers |
04/13/2011 | EP1140085B1 Azabicycloalkanes as ccr5 modulators |